OncoMatch/Clinical Trials/NCT02025023
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
Is NCT02025023 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies multiple treatments including 5-fluorouracil and Triamcinolone Acetonide for chalazion.
Treatment: 5-fluorouracil · Triamcinolone Acetonide · Triamcinolone Acetonide/5-fluorouracil mixture — Local injection of 5-fluorouracil into a chalazion (stye) is as effective as local injection of triamcinolone (steroid) and incision and curettage for treatment of chalazia.
Check if I qualifyEligibility summary
For patients with Chalazion.
This summary was generated by AI from the trial's official eligibility criteria and may contain errors. Always confirm with the study team before contacting a site.
US trial sites
- University of Washington Eye Institute at Harborview · Seattle, Washington
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify